Legacy Wealth Asset Management LLC purchased a new stake in Plexus Corp. (NASDAQ:PLXS – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 1,587 shares of the technology company’s stock, valued at approximately $217,000.
Other hedge funds have also recently bought and sold shares of the company. Quest Partners LLC increased its stake in shares of Plexus by 36,700.0% during the second quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after purchasing an additional 367 shares during the period. Innealta Capital LLC acquired a new stake in shares of Plexus during the second quarter worth $51,000. GAMMA Investing LLC boosted its position in shares of Plexus by 190.1% in the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after acquiring an additional 498 shares during the period. EntryPoint Capital LLC grew its stake in shares of Plexus by 56.2% in the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after acquiring an additional 351 shares in the last quarter. Finally, nVerses Capital LLC bought a new position in Plexus during the third quarter worth about $178,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.
Plexus Stock Performance
Shares of NASDAQ:PLXS opened at $141.19 on Friday. Plexus Corp. has a 1 year low of $88.57 and a 1 year high of $153.60. The stock has a market capitalization of $3.84 billion, a price-to-earnings ratio of 35.56 and a beta of 0.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 0.64. The company’s 50 day simple moving average is $130.82 and its 200 day simple moving average is $116.26.
Insiders Place Their Bets
In related news, CEO Todd P. Kelsey sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $123.75, for a total transaction of $123,750.00. Following the completion of the transaction, the chief executive officer now directly owns 87,026 shares in the company, valued at $10,769,467.50. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Plexus news, insider Steven J. Frisch sold 6,048 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $123.99, for a total value of $749,891.52. Following the completion of the transaction, the insider now directly owns 30,070 shares in the company, valued at approximately $3,728,379.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Todd P. Kelsey sold 1,000 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $123.75, for a total value of $123,750.00. Following the sale, the chief executive officer now owns 87,026 shares in the company, valued at approximately $10,769,467.50. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,113 shares of company stock valued at $2,541,394. 2.39% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of analysts have issued reports on PLXS shares. Benchmark reissued a “buy” rating and issued a $150.00 price objective on shares of Plexus in a report on Monday, October 21st. KeyCorp initiated coverage on Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating on the stock. Finally, Needham & Company LLC lifted their price objective on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a report on Friday. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $129.75.
Get Our Latest Stock Analysis on Plexus
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories
- Five stocks we like better than Plexus
- Business Services Stocks Investing
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Short Selling: How to Short a Stock
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.